Skip to main content
. 2020 Oct 8;12(10):2884. doi: 10.3390/cancers12102884

Table 3.

Antibodies used in this study.

Protein Primary Antibody Source Application Dilution
PCNA anti-PCNA Santa Cruz, TX, USA
Cell Signaling, MA, USA
WB
IF
1:1000
1:200
Human neutrophil Anti-Myeloperoxidase Abcam, MA, IHC 1:100
GAPDH Anti GAPDH: sc-53;02 Santa Cruz, TX WB 1:2000
Anti-Histone H3 (citrulline R2 + R8 + R17): ab5103 Abcam, MA, IF 1:200